Pharma major, Dr Reddy's Laboratories has raised Rs 1,077 crore debt in the present quarter through its subsidiaries in Switzerland, which entered into a loan agreement with a consortium of International banks to borrow the sum money of Rs 1,077.50 crore. The company has raised these funds for fulfilling working capital provisions and also refinancing previous loans. The term of the loan is for sixty months starting from September 30, 2011.
Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1777.65 |
Dr. Reddys Lab | 1194.55 |
Cipla | 1465.65 |
Lupin | 2043.30 |
Zydus Lifesciences | 944.25 |
View more.. |